DNLI financials
Denali Therapeutics (DNLI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DNLI income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$11.18M | -$555.34M | -$512.54M | -2.97 |
| 2024 | $0.00 | $0.00 | -$487.34M | -$422.77M | -2.57 |
| 2023 | $330.53M | $330.53M | -$196.70M | -$145.22M | -1.06 |
| 2022 | $108.46M | $108.46M | -$340.74M | -$325.99M | -2.60 |
| 2021 | $48.66M | $48.66M | -$295.75M | -$290.58M | -2.39 |
| 2020 | $335.66M | $335.66M | $62.72M | $71.14M | 0.63 |